1. Home
  2. ATXS vs NWPX Comparison

ATXS vs NWPX Comparison

Compare ATXS & NWPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATXS
  • NWPX
  • Stock Information
  • Founded
  • ATXS 2008
  • NWPX 1966
  • Country
  • ATXS United States
  • NWPX United States
  • Employees
  • ATXS N/A
  • NWPX N/A
  • Industry
  • ATXS Biotechnology: Pharmaceutical Preparations
  • NWPX Steel/Iron Ore
  • Sector
  • ATXS Health Care
  • NWPX Industrials
  • Exchange
  • ATXS Nasdaq
  • NWPX Nasdaq
  • Market Cap
  • ATXS 401.2M
  • NWPX 449.0M
  • IPO Year
  • ATXS 2015
  • NWPX 1995
  • Fundamental
  • Price
  • ATXS $6.81
  • NWPX $47.81
  • Analyst Decision
  • ATXS Strong Buy
  • NWPX Buy
  • Analyst Count
  • ATXS 6
  • NWPX 2
  • Target Price
  • ATXS $25.67
  • NWPX $47.50
  • AVG Volume (30 Days)
  • ATXS 244.9K
  • NWPX 83.9K
  • Earning Date
  • ATXS 03-03-2025
  • NWPX 02-26-2025
  • Dividend Yield
  • ATXS N/A
  • NWPX N/A
  • EPS Growth
  • ATXS N/A
  • NWPX 25.64
  • EPS
  • ATXS N/A
  • NWPX 2.94
  • Revenue
  • ATXS N/A
  • NWPX $483,085,000.00
  • Revenue This Year
  • ATXS N/A
  • NWPX $13.22
  • Revenue Next Year
  • ATXS N/A
  • NWPX $0.28
  • P/E Ratio
  • ATXS N/A
  • NWPX $16.26
  • Revenue Growth
  • ATXS N/A
  • NWPX 9.54
  • 52 Week Low
  • ATXS $6.64
  • NWPX $28.57
  • 52 Week High
  • ATXS $16.90
  • NWPX $57.76
  • Technical
  • Relative Strength Index (RSI)
  • ATXS 31.94
  • NWPX 39.90
  • Support Level
  • ATXS $6.77
  • NWPX $49.75
  • Resistance Level
  • ATXS $7.30
  • NWPX $53.46
  • Average True Range (ATR)
  • ATXS 0.30
  • NWPX 1.46
  • MACD
  • ATXS 0.02
  • NWPX -0.19
  • Stochastic Oscillator
  • ATXS 14.66
  • NWPX 5.52

About ATXS Astria Therapeutics Inc.

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

About NWPX Northwest Pipe Company

Northwest Pipe Co is a manufacturer of water-related infrastructure products. The company has two operating segments; Engineered Steel Pressure Pipe segment manufactures large-diameter, high-pressure steel pipeline systems for use in water infrastructure applications, which are related to drinking water systems. These products are also used for hydroelectric power systems, wastewater systems, seismic resiliency, and other applications, and Precast Infrastructure and Engineered Systems segment manufacture stormwater and wastewater technology products, high-quality precast and reinforced concrete products, including manholes, box culverts, vaults, and catch basins, pump lift stations, oil water separators, biofiltration, and other environmental and engineered solutions.

Share on Social Networks: